Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondria in steatohepatitis.

D Pessayre1, A Berson, B Fromenty

  • 1INSERM-U481 and Centre de Recherche de l'Association Claude Bernard sur les Hépatites Virales, Hôpital Beaujon, 92118 Clichy, France. pessayre@bichat.inserm.fr

Seminars in Liver Disease
|April 12, 2001
PubMed
Summary

Lifestyle changes in affluent nations contribute to hepatic steatosis (fatty liver disease). Mitochondrial dysfunction and oxidative stress worsen this condition, potentially leading to liver damage and fibrosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute presentation of cocoon abdomen as intestinal obstruction mimicking with strangulated eventration: A case report.

International journal of surgery case reports·2024
Same author

[Ultrawide-field fundus photography showing frosted branch angiitis].

Journal francais d'ophtalmologie·2024
Same author

Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet.

Pharmacological research·2023
Same author

3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments.

Toxicology in vitro : an international journal published in association with BIBRA·2023
Same author

Clinophobia: Dermatologists on the front line (16 cases).

Annales de dermatologie et de venereologie·2021
Same author

WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies.

Revue neurologique·2020

Area of Science:

  • Hepatology
  • Mitochondrial Biology
  • Oxidative Stress

Background:

  • Affluent populations face rising rates of obesity, diabetes, and hypertriglyceridemia, linked by insulin resistance.
  • These metabolic conditions contribute to hepatic steatosis (fatty liver disease), which can progress to necroinflammation and fibrosis.
  • Mitochondria are central to energy production and fat oxidation but are also a primary source of reactive oxygen species (ROS).

Purpose of the Study:

  • To explore the role of mitochondrial dysfunction and oxidative stress in the pathogenesis of hepatic steatosis.
  • To investigate the mechanisms linking metabolic syndrome to liver damage.
  • To differentiate between primary and secondary steatohepatitis concerning mitochondrial ROS production.

Main Methods:

Related Experiment Videos

  • Analysis of mitochondrial function in patients with steatohepatitis, including ATP synthesis and respiratory chain activity.
  • Assessment of reactive oxygen species (ROS) production and lipid peroxidation in liver tissues.
  • Evaluation of antioxidant status, including vitamin E levels, and response to supplementation.

    • Main Results:

    • Patients with primary steatohepatitis show mitochondrial lesions, impaired ATP synthesis, and increased ROS leakage.
    • Mitochondrial ROS may oxidize hepatic fat, leading to lipid peroxidation and further mitochondrial damage, creating a vicious cycle.
    • Secondary steatohepatitis exhibits exacerbated mitochondrial ROS formation due to underlying causative factors, potentially intensifying liver injury and fibrogenesis.

    Conclusions:

    • Mitochondrial dysfunction and oxidative stress are key contributors to the progression of hepatic steatosis to steatohepatitis.
    • Therapeutic strategies targeting mitochondrial health and oxidative stress may be beneficial for managing fatty liver disease.
    • Understanding the distinct mechanisms in primary versus secondary steatohepatitis is crucial for targeted treatment approaches.